ITT Equity Method Investments increased by 2.0% to $41.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from $42.50M to $41.80M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 28.5% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.40M | $14.20M | $14.50M | $15.20M | $41.10M | $42.70M | $42.90M | $43.60M | $45.30M | $45.70M | $46.60M | $47.80M | $47.40M | $47.80M | $48.50M | $42.50M | $42.00M | $40.30M | $41.00M | $41.80M |
| QoQ Change | — | +14.5% | +2.1% | +4.8% | +170.4% | +3.9% | +0.5% | +1.6% | +3.9% | +0.9% | +2.0% | +2.6% | -0.8% | +0.8% | +1.5% | -12.4% | -1.2% | -4.0% | +1.7% | +2.0% |
| YoY Change | — | — | — | — | +231.5% | +200.7% | +195.9% | +186.8% | +10.2% | +7.0% | +8.6% | +9.6% | +4.6% | +4.6% | +4.1% | -11.1% | -11.4% | -15.7% | -15.5% | -1.6% |